Abstract 1933: Discovery of first-in-class small molecule CD99 inhibitors for targeted therapy of Ewing sarcoma

Haydar Çelik; Marika Sciandra; B. Flashner; Elif Gelmez; Neslihan Kayraklıoğlu; David V. Allegakoen; Jeff R. Petro; Erin J. Conn; Sarah Hour; Jenny Han

doi:10.1158/1538-7445.am2017-1933

Abstract 1933: Discovery of first-in-class small molecule CD99 inhibitors for targeted therapy of Ewing sarcoma

Identifier:nobleid.org/w1/20260515/2AC36D17

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2AC36D17.svg?ark=w1%2F20260515%2F2AC36D17)](https://nobleid.org/work/w1/20260515/2AC36D17)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Neslihan Kayraklıoğlu

Claim authorship of this work

Abstract 1933: Discovery of first-in-class small molecule CD99 inhibitors for targeted therapy of Ewing sarcoma

Identifier:nobleid.org/w1/20260515/2AC36D17

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2AC36D17.svg?ark=w1%2F20260515%2F2AC36D17)](https://nobleid.org/work/w1/20260515/2AC36D17)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Neslihan Kayraklıoğlu

Claim authorship of this work